SAFETY INFORMATION
Signal word | Warning |
---|---|
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H302:Acute toxicity,oral |
Precautionary Statement Codes |
P280:Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
COMPUTED DESCRIPTORS
Molecular Weight | 189.17 g/mol |
---|---|
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 189.042593085 g/mol |
Monoisotopic Mass | 189.042593085 g/mol |
Topological Polar Surface Area | 66.4 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 309 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
Description
4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID is a novel HIV-1 integrase strand transfer inhibitor.
RELATED SUPPLIERS
Vidgas science and technologies Pvt Ltd
1Y
product:4-Oxo-1,4-dihydro-quinoline-3-carboxylic acid 13721-01-2 98%
Synergene Active Ingredients Pvt. Ltd.
1Y
product:13721-01-2 4-Oxo-1,2-dihydro-quinoline-3-carboxylic acid 98%
Orgamine Chemicals(I) Pvt Ltd
1Y
product:4-Oxo-1,2-dihydro-quinoline-3-carboxylic acid 13721-01-2 98%